Cite
HARVARD Citation
Sands, B. et al. (n.d.). DOP026 Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open. Journal of Crohn's and colitis. p. S049. [Online].